Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 3/20 | 0.47 |
| ▸ | ADH1A | P07327 | 3/20 | 0.47 |
| ▸ | ADH7 | P40394 | 3/20 | 0.47 |
| ▸ | ADH1C | P00326 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.41 |
| ▸ | ADH4 | P08319 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28153306 | 0.76 | ADH1B (0.54) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL17227566 | 0.71 | EPHX1 (0.47) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL8581471 | 0.71 | PTPN1 (0.46) | PTPN1TSHRALOX15 | |
| SCHEMBL8581469 | 0.71 | PTPN1 (0.46) | PTPN1TSHRALOX15 | |
| SCHEMBL14034561 | 0.70 | EPHX1 (0.38) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL11775863 | 0.70 | EPHX1 (0.60) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL11775859 | 0.70 | EPHX1 (0.60) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL18965744 | 0.70 | ADH1B (0.60) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL28179459 | 0.69 | EPHX1 (0.59) | ADH1BADH1AADH7ADH1CEPHX1 | |
| SCHEMBL28218181 | 0.69 | EPHX1 (0.59) | ADH1BADH1AADH7ADH1CEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020252760-A1 | CONTROLLABLE LONG PERSISTENT LUMINESCENT MATERIAL | 复旦大学 | 2020-12-24 | — | — | WO | disclosed |